Proscia was recently recognized as a top 10 startup to watch by Clinical OMICs in an article highlighting startups using AI and other disruptive technologies to deliver on the promise of precision medicine.
“At Proscia, we’re accelerating pathology’s shift from analog to digital, enabling life sciences organizations, health systems, and laboratories around the world to make this transition,” Mike Bonham, M.D., Ph.D., Proscia’s CMO, told Clinical OMICs.
Read more about how Proscia and other disruptors are delivering the future of precision medicine.
New to digital pathology? Learn how whole slide imaging is changing the industry here.